Nunez R A, Cass S P, Furman J M
Department of Otolaryngology, University of Pittsburgh, Pennsylvania, USA.
Otolaryngol Head Neck Surg. 2000 May;122(5):647-52. doi: 10.1016/S0194-5998(00)70190-2.
This is a prospective, nonrandomized study of the canalith repositioning procedure (CRP) for treatment of benign paroxysmal positional vertigo (BPPV). CRP was used to treat 168 patients with BPPV. Patient data were gathered by yearly telephone interviews to determine whether symptoms of position-induced vertigo had returned. After 1 or 2 treatment sessions 91.3% of patients reported complete symptom resolution. Average follow-up for the study population after the initial treatment was 26 months. A recurrence rate of 26.8% was found among those patients who initially reported resolution of symptoms after CRP. Application of recurrence data to a Kaplan-Meier estimation suggests a 15% recurrence rate per year of BPPV, with a 50% recurrence rate of BPPV at 40 months after treatment. There was no significant association between cure or recurrence rate and sex, age, duration of symptoms, presumed cause, or treating physician.
这是一项关于用于治疗良性阵发性位置性眩晕(BPPV)的耳石复位程序(CRP)的前瞻性、非随机研究。CRP用于治疗168例BPPV患者。通过每年的电话访谈收集患者数据,以确定位置性眩晕症状是否复发。经过1或2次治疗后,91.3%的患者报告症状完全缓解。初始治疗后研究人群的平均随访时间为26个月。在最初报告CRP后症状缓解的患者中,复发率为26.8%。将复发数据应用于Kaplan-Meier估计表明,BPPV的年复发率为15%,治疗后40个月BPPV的复发率为50%。治愈率或复发率与性别、年龄、症状持续时间、推测病因或治疗医生之间无显著关联。